These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

217 related articles for article (PubMed ID: 22194493)

  • 1. Proton MR spectroscopy in metabolic assessment of musculoskeletal lesions.
    Subhawong TK; Wang X; Durand DJ; Jacobs MA; Carrino JA; Machado AJ; Fayad LM
    AJR Am J Roentgenol; 2012 Jan; 198(1):162-72. PubMed ID: 22194493
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Proton magnetic resonance spectroscopy of musculoskeletal lesions at 3 T with metabolite quantification.
    Lee CW; Lee JH; Kim DH; Min HS; Park BK; Cho HS; Kang HG; Suh JS; Ehara S
    Clin Imaging; 2010; 34(1):47-52. PubMed ID: 20122519
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Characterization of musculoskeletal lesions on 3-T proton MR spectroscopy.
    Fayad LM; Barker PB; Jacobs MA; Eng J; Weber KL; Kulesza P; Bluemke DA
    AJR Am J Roentgenol; 2007 Jun; 188(6):1513-20. PubMed ID: 17515370
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A feasibility study of quantitative molecular characterization of musculoskeletal lesions by proton MR spectroscopy at 3 T.
    Fayad LM; Wang X; Salibi N; Barker PB; Jacobs MA; Machado AJ; Weber KL; Bluemke DA
    AJR Am J Roentgenol; 2010 Jul; 195(1):W69-75. PubMed ID: 20566784
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Musculoskeletal tumors: how to use anatomic, functional, and metabolic MR techniques.
    Fayad LM; Jacobs MA; Wang X; Carrino JA; Bluemke DA
    Radiology; 2012 Nov; 265(2):340-56. PubMed ID: 23093707
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Molecular characterization of musculoskeletal tumors by proton MR spectroscopy.
    Fayad LM; Barker PB; Bluemke DA
    Semin Musculoskelet Radiol; 2007 Sep; 11(3):240-5. PubMed ID: 18260034
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Imaging of musculoskeletal tumors : what are new MR techniques capable of and what is included in an optimal MR protocol?].
    Weber MA
    Radiologe; 2013 May; 53(5):396-8. PubMed ID: 23588895
    [No Abstract]   [Full Text] [Related]  

  • 8. In vivo proton spectroscopy of giant cell tumor of the bone.
    Sah PL; Sharma R; Kandpal H; Seith A; Rastogi S; Bandhu S; Jagannathan NR
    AJR Am J Roentgenol; 2008 Feb; 190(2):W133-9. PubMed ID: 18212197
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Qualitative 3-T Proton MR Spectroscopy for the Characterization of Musculoskeletal Neoplasms: Update on Diagnostic Performance and Indications.
    Gondim Teixeira PA; Ledrich M; Kauffmann F; Wamba JM; Felblinger J; Blum A; Hossu G
    AJR Am J Roentgenol; 2017 Jun; 208(6):1312-1319. PubMed ID: 28301222
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Characterization of bone and soft-tissue tumors with in vivo 1H MR spectroscopy: initial results.
    Wang CK; Li CW; Hsieh TJ; Chien SH; Liu GC; Tsai KB
    Radiology; 2004 Aug; 232(2):599-605. PubMed ID: 15286325
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Longitudinally monitoring chemotherapy effect of malignant musculoskeletal tumors with in vivo proton magnetic resonance spectroscopy: an initial experience.
    Hsieh TJ; Li CW; Chuang HY; Liu GC; Wang CK
    J Comput Assist Tomogr; 2008; 32(6):987-94. PubMed ID: 19204465
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Application value of 3T ¹H-magnetic resonance spectroscopy in diagnosing breast tumors.
    Vassiou K; Tsougos I; Kousi E; Vlychou M; Athanasiou E; Theodorou K; Arvanitis DL; Fezoulidis IV
    Acta Radiol; 2013 May; 54(4):380-8. PubMed ID: 23436823
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Musculoskeletal tumors: use of proton MR spectroscopic imaging for characterization.
    Fayad LM; Bluemke DA; McCarthy EF; Weber KL; Barker PB; Jacobs MA
    J Magn Reson Imaging; 2006 Jan; 23(1):23-8. PubMed ID: 16315208
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Study of single voxel 1H MR spectroscopy of bone tumors: differentiation of benign from malignant tumors.
    Zhang J; Cheng K; Ding Y; Liang W; Ding Y; Vanel D; Cheng X
    Eur J Radiol; 2013 Dec; 82(12):2124-8. PubMed ID: 22169357
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Proton MR spectroscopy with choline peak as malignancy marker improves positive predictive value for breast cancer diagnosis: preliminary study.
    Bartella L; Morris EA; Dershaw DD; Liberman L; Thakur SB; Moskowitz C; Guido J; Huang W
    Radiology; 2006 Jun; 239(3):686-92. PubMed ID: 16603660
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Carbon-11 choline positron emission tomography in musculoskeletal tumors: comparison with fluorine-18 fluorodeoxyglucose positron emission tomography.
    Yanagawa T; Watanabe H; Inoue T; Ahmed AR; Tomiyoshi K; Shinozaki T; Oriuchi N; Endo K; Takagishi K
    J Comput Assist Tomogr; 2003; 27(2):175-82. PubMed ID: 12703009
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterisation of musculoskeletal tumours by multivoxel proton MR spectroscopy.
    Patni RS; Boruah DK; Sanyal S; Gogoi BB; Patni M; Khandelia R; Gogoi N
    Skeletal Radiol; 2017 Apr; 46(4):483-495. PubMed ID: 28188338
    [TBL] [Abstract][Full Text] [Related]  

  • 18. In vivo characterisation of soft tissue tumours by 1.5-T proton MR spectroscopy.
    Russo F; Mazzetti S; Grignani G; De Rosa G; Aglietta M; Anselmetti GC; Stasi M; Regge D
    Eur Radiol; 2012 May; 22(5):1131-9. PubMed ID: 22138734
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Value of 3T magnetic resonance dynamic contrast-enhanced and diffusion-weighted imaging in differential diagnosis of musculoskeletal tumors].
    Qi ZH; Li CF; Ma XX; Yang H; Jiang BD; Zhang K; Yu DX
    Zhongguo Yi Xue Ke Xue Yuan Xue Bao; 2012 Apr; 34(2):138-45. PubMed ID: 22776599
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diffusion-weighted magnetic resonance imaging for the evaluation of musculoskeletal tumors.
    Costa FM; Ferreira EC; Vianna EM
    Magn Reson Imaging Clin N Am; 2011 Feb; 19(1):159-80. PubMed ID: 21129640
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.